Logo image of ICL

ICL GROUP LTD (ICL) Stock Fundamental Analysis

USA - NYSE:ICL - IL0002810146 - Common Stock

6.11 USD
+0.03 (+0.49%)
Last: 9/23/2025, 9:47:29 AM
Fundamental Rating

5

Overall ICL gets a fundamental rating of 5 out of 10. We evaluated ICL against 83 industry peers in the Chemicals industry. ICL scores excellent on profitability, but there are some minor concerns on its financial health. ICL has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

ICL had positive earnings in the past year.
ICL had a positive operating cash flow in the past year.
Each year in the past 5 years ICL has been profitable.
ICL had a positive operating cash flow in each of the past 5 years.
ICL Yearly Net Income VS EBIT VS OCF VS FCFICL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

1.2 Ratios

ICL has a Return On Assets of 2.97%. This is in the better half of the industry: ICL outperforms 63.86% of its industry peers.
ICL has a better Return On Equity (6.10%) than 68.67% of its industry peers.
Looking at the Return On Invested Capital, with a value of 5.24%, ICL is in the better half of the industry, outperforming 60.24% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ICL is significantly above the industry average of 6.34%.
The last Return On Invested Capital (5.24%) for ICL is well below the 3 year average (13.86%), which needs to be investigated, but indicates that ICL had better years and this may not be a problem.
Industry RankSector Rank
ROA 2.97%
ROE 6.1%
ROIC 5.24%
ROA(3y)9.18%
ROA(5y)6.94%
ROE(3y)19.28%
ROE(5y)15.08%
ROIC(3y)13.86%
ROIC(5y)10.81%
ICL Yearly ROA, ROE, ROICICL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

1.3 Margins

The Profit Margin of ICL (5.28%) is better than 71.08% of its industry peers.
ICL's Profit Margin has declined in the last couple of years.
ICL has a Operating Margin of 10.46%. This is in the better half of the industry: ICL outperforms 60.24% of its industry peers.
ICL's Operating Margin has declined in the last couple of years.
The Gross Margin of ICL (32.29%) is better than 60.24% of its industry peers.
ICL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.46%
PM (TTM) 5.28%
GM 32.29%
OM growth 3Y-13.01%
OM growth 5Y-4.18%
PM growth 3Y-19.15%
PM growth 5Y-7.97%
GM growth 3Y-4.23%
GM growth 5Y-0.88%
ICL Yearly Profit, Operating, Gross MarginsICL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ICL is creating value.
ICL has about the same amout of shares outstanding than it did 1 year ago.
ICL has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ICL has an improved debt to assets ratio.
ICL Yearly Shares OutstandingICL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
ICL Yearly Total Debt VS Total AssetsICL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

An Altman-Z score of 2.35 indicates that ICL is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.35, ICL is doing good in the industry, outperforming 65.06% of the companies in the same industry.
ICL has a debt to FCF ratio of 6.12. This is a slightly negative value and a sign of low solvency as ICL would need 6.12 years to pay back of all of its debts.
ICL has a Debt to FCF ratio of 6.12. This is in the better half of the industry: ICL outperforms 75.90% of its industry peers.
A Debt/Equity ratio of 0.42 indicates that ICL is not too dependend on debt financing.
ICL has a Debt to Equity ratio of 0.42. This is in the better half of the industry: ICL outperforms 71.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 6.12
Altman-Z 2.35
ROIC/WACC0.69
WACC7.62%
ICL Yearly LT Debt VS Equity VS FCFICL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

ICL has a Current Ratio of 1.75. This is a normal value and indicates that ICL is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.75, ICL is not doing good in the industry: 60.24% of the companies in the same industry are doing better.
A Quick Ratio of 1.05 indicates that ICL should not have too much problems paying its short term obligations.
The Quick ratio of ICL (1.05) is worse than 63.86% of its industry peers.
Industry RankSector Rank
Current Ratio 1.75
Quick Ratio 1.05
ICL Yearly Current Assets VS Current LiabilitesICL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

3

3. Growth

3.1 Past

The earnings per share for ICL have decreased by -7.50% in the last year.
ICL shows a decrease in Revenue. In the last year, the revenue decreased by -1.22%.
Measured over the past years, ICL shows a small growth in Revenue. The Revenue has been growing by 5.35% on average per year.
EPS 1Y (TTM)-7.5%
EPS 3Y-16.38%
EPS 5Y0%
EPS Q2Q%-10%
Revenue 1Y (TTM)-1.22%
Revenue growth 3Y-0.55%
Revenue growth 5Y5.35%
Sales Q2Q%4.57%

3.2 Future

ICL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.56% yearly.
ICL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.13% yearly.
EPS Next Y-3.39%
EPS Next 2Y12.89%
EPS Next 3Y12.56%
EPS Next 5YN/A
Revenue Next Year3.8%
Revenue Next 2Y4.5%
Revenue Next 3Y4.13%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ICL Yearly Revenue VS EstimatesICL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
ICL Yearly EPS VS EstimatesICL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 16.51 indicates a correct valuation of ICL.
ICL's Price/Earnings ratio is a bit cheaper when compared to the industry. ICL is cheaper than 65.06% of the companies in the same industry.
When comparing the Price/Earnings ratio of ICL to the average of the S&P500 Index (27.41), we can say ICL is valued slightly cheaper.
ICL is valuated correctly with a Price/Forward Earnings ratio of 12.62.
67.47% of the companies in the same industry are more expensive than ICL, based on the Price/Forward Earnings ratio.
ICL is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.87, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.51
Fwd PE 12.62
ICL Price Earnings VS Forward Price EarningsICL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ICL is valued a bit cheaper than 74.70% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ICL is valued a bit cheaper than 73.49% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.57
EV/EBITDA 7.5
ICL Per share dataICL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

ICL has a very decent profitability rating, which may justify a higher PE ratio.
ICL's earnings are expected to grow with 12.56% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.89%
EPS Next 3Y12.56%

4

5. Dividend

5.1 Amount

ICL has a Yearly Dividend Yield of 3.07%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.47, ICL pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.38, ICL pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.07%

5.2 History

The dividend of ICL decreases each year by -1.81%.
ICL has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-1.81%
Div Incr Years0
Div Non Decr Years0
ICL Yearly Dividends per shareICL Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

64.85% of the earnings are spent on dividend by ICL. This is not a sustainable payout ratio.
DP64.85%
EPS Next 2Y12.89%
EPS Next 3Y12.56%
ICL Yearly Income VS Free CF VS DividendICL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B
ICL Dividend Payout.ICL Dividend Payout, showing the Payout Ratio.ICL Dividend Payout.PayoutRetained Earnings

ICL GROUP LTD

NYSE:ICL (9/23/2025, 9:47:29 AM)

6.11

+0.03 (+0.49%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-10 2025-11-10
Inst Owners23.58%
Inst Owner Change3.18%
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap7.89B
Analysts47.5
Price Target0.02 (-99.67%)
Short Float %0.22%
Short Ratio2.34
Dividend
Industry RankSector Rank
Dividend Yield 3.07%
Yearly Dividend0.19
Dividend Growth(5Y)-1.81%
DP64.85%
Div Incr Years0
Div Non Decr Years0
Ex-Date09-03 2025-09-03 (0.1442436)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-9.62%
Min EPS beat(2)-18.25%
Max EPS beat(2)-0.99%
EPS beat(4)2
Avg EPS beat(4)1.71%
Min EPS beat(4)-18.25%
Max EPS beat(4)25.18%
EPS beat(8)6
Avg EPS beat(8)9.5%
EPS beat(12)7
Avg EPS beat(12)6.24%
EPS beat(16)11
Avg EPS beat(16)18.56%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-69.34%
PT rev (3m)-67.72%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-15.38%
EPS NY rev (1m)0%
EPS NY rev (3m)-16.24%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.9%
Revenue NY rev (3m)1.38%
Valuation
Industry RankSector Rank
PE 16.51
Fwd PE 12.62
P/S 1.13
P/FCF 16.57
P/OCF 6.09
P/B 1.31
P/tB 1.55
EV/EBITDA 7.5
EPS(TTM)0.37
EY6.06%
EPS(NY)0.48
Fwd EY7.93%
FCF(TTM)0.37
FCFY6.04%
OCF(TTM)1
OCFY16.41%
SpS5.39
BVpS4.66
TBVpS3.93
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.97%
ROE 6.1%
ROCE 7.31%
ROIC 5.24%
ROICexc 5.64%
ROICexgc 6.28%
OM 10.46%
PM (TTM) 5.28%
GM 32.29%
FCFM 6.85%
ROA(3y)9.18%
ROA(5y)6.94%
ROE(3y)19.28%
ROE(5y)15.08%
ROIC(3y)13.86%
ROIC(5y)10.81%
ROICexc(3y)14.67%
ROICexc(5y)11.45%
ROICexgc(3y)16.24%
ROICexgc(5y)12.7%
ROCE(3y)19.96%
ROCE(5y)15.59%
ROICexcg growth 3Y-15.7%
ROICexcg growth 5Y-1.81%
ROICexc growth 3Y-15.48%
ROICexc growth 5Y-2.08%
OM growth 3Y-13.01%
OM growth 5Y-4.18%
PM growth 3Y-19.15%
PM growth 5Y-7.97%
GM growth 3Y-4.23%
GM growth 5Y-0.88%
F-Score5
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 6.12
Debt/EBITDA 1.92
Cap/Depr 136.79%
Cap/Sales 11.76%
Interest Coverage 6.21
Cash Conversion 97.66%
Profit Quality 129.7%
Current Ratio 1.75
Quick Ratio 1.05
Altman-Z 2.35
F-Score5
WACC7.62%
ROIC/WACC0.69
Cap/Depr(3y)138.38%
Cap/Depr(5y)133.57%
Cap/Sales(3y)9.41%
Cap/Sales(5y)9.89%
Profit Quality(3y)123.56%
Profit Quality(5y)409.37%
High Growth Momentum
Growth
EPS 1Y (TTM)-7.5%
EPS 3Y-16.38%
EPS 5Y0%
EPS Q2Q%-10%
EPS Next Y-3.39%
EPS Next 2Y12.89%
EPS Next 3Y12.56%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.22%
Revenue growth 3Y-0.55%
Revenue growth 5Y5.35%
Sales Q2Q%4.57%
Revenue Next Year3.8%
Revenue Next 2Y4.5%
Revenue Next 3Y4.13%
Revenue Next 5YN/A
EBIT growth 1Y-7.97%
EBIT growth 3Y-13.49%
EBIT growth 5Y0.95%
EBIT Next Year73.14%
EBIT Next 3Y23.84%
EBIT Next 5YN/A
FCF growth 1Y-57.35%
FCF growth 3Y18.48%
FCF growth 5Y12.66%
OCF growth 1Y-29.9%
OCF growth 3Y11.29%
OCF growth 5Y8.15%